Noninvasive Imaging of Immune Checkpoint Ligand PD-L1 in Tumors and Metastases for Guiding Immunotherapy.
about
Clinical characteristics of patient selection and imaging predictors of outcome in solid tumors treated with checkpoint-inhibitors.Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop.Role of noninvasive molecular imaging in determining response
P2860
Noninvasive Imaging of Immune Checkpoint Ligand PD-L1 in Tumors and Metastases for Guiding Immunotherapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Noninvasive Imaging of Immune ...... ses for Guiding Immunotherapy.
@en
Noninvasive Imaging of Immune ...... ses for Guiding Immunotherapy.
@nl
type
label
Noninvasive Imaging of Immune ...... ses for Guiding Immunotherapy.
@en
Noninvasive Imaging of Immune ...... ses for Guiding Immunotherapy.
@nl
prefLabel
Noninvasive Imaging of Immune ...... ses for Guiding Immunotherapy.
@en
Noninvasive Imaging of Immune ...... ses for Guiding Immunotherapy.
@nl
P2093
P2860
P356
P1476
Noninvasive Imaging of Immune ...... ses for Guiding Immunotherapy.
@en
P2093
Samit Chatterjee
Sridhar Nimmagadda
Wojciech G Lesniak
P2860
P304
1536012117718459
P356
10.1177/1536012117718459
P577
2017-01-01T00:00:00Z